AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.12.24	AstraZeneca's Alexion Inks Deal With Pan-Canadian Pharmaceutical Alliance (RTTNews)
12.12.24	HUTCHMED: ORPATHYS And TAGRISSO Get Breakthrough Therapy Designation In China For NSCLC (RTTNews)
06.12.24	AZN : TROPION Analysis Reveals Datopotamab Deruxtecan Efficacy In Advanced EGFR-Mutated Lung Cancer (RTTNews)
05.12.24	AstraZeneca: FDA Approves Imfinzi To Treat Adult Patients With Limited-stage Small Cell Lung Cancer (RTTNews)
05.12.24	FDA Approves AstraZeneca's Imfinzi For Limited-Stage Small Cell Lung Cancer (RTTNews)
02.12.24	Biotech Stocks Facing FDA Decision In December 2024 (RTTNews)
29.11.24	Study Says Benralizumab Could Treat Asthma Attacks (RTTNews)
28.11.24	HUTCHMED Announces Renewal Of ORPATHYS Inclusion In China's NRDL (RTTNews)
25.11.24	AstraZeneca: Truqap Combination In Phase III Trial Shows Improvement In Advanced Prostate Cancer (RTTNews)
18.11.24	Lunit Collaborates With AstraZeneca To Develop AI-powered Digital Pathology Solutions (RTTNews)
12.11.24	AstraZeneca: Koselugo Phase III Trial Meets Primary Goal In Adults With Neurofibromatosis Type 1 (RTTNews)
12.11.24	AstraZeneca To Invest $3.5 Bln In US To Expand R&D And Manufacturing (RTTNews)
12.11.24	AstraZeneca Q3 Net Income Rises; Upgrades 2024 Guidance (RTTNews)
30.10.24	Chinese Authorities Probe AstraZeneca China President (RTTNews)
21.10.24	AstraZeneca : Wainzua Recommended By CHMP For EU Approval In Hereditary Transthyretin Amyloidosis (RTTNews)
07.10.24	AstraZeneca Reports Positive Results From BATURA Phase IIIb Trial - Quick Facts (RTTNews)
02.10.24	Arcus Announces Clinical Trial Collaboration With AstraZeneca To Evaluate Casdatifan (RTTNews)
26.09.24	AstraZeneca: FDA Approves Tagrisso To Treat Unresectable Stage III Lung Cancer (RTTNews)
23.09.24	AstraZeneca: TROPION-Breast01 Phase III Trial Fails To Achieve Statistical Significance (RTTNews)
19.09.24	AIM Reports Positive Preliminary Data From Phase 1b/2 Study Of Ampligen, Imfinzi As Combination (RTTNews)
18.09.24	AstraZeneca: Fasenra Approved By FDA To Treat Eosinophilic Granulomatosis With Polyangiitis (RTTNews)
15.09.24	AZN : IMFINZI Regimen Reduces Death Risk By 25% In Late-Stage Muscle-Invasive Bladder Cancer Trial (RTTNews)
10.09.24	SOPHiA Genetics, AstraZeneca Team Up To Expand Liquid Biopsy Testing To 20 New Locations Globally (RTTNews)
10.09.24	AstraZeneca :Dato-DXd Fails To Significantly Improve Overall Survival In Phase III Lung Cancer Trial (RTTNews)
05.09.24	Chinese Authorities Detain AstraZeneca Employees (RTTNews)
01.09.24	Weekly Biotech Buzz: BMRN Cuts Jobs, FDA Approves New Mpox Vaccine, MRK Halts 2 Keytruda Studies (RTTNews)
19.08.24	AZN: Enhertu Gets US Breakthrough Therapy Designation For HER2 Low/Ultralow Metastatic Breast Cancer (RTTNews)
18.08.24	Biotech Buzz: VIRX Cuts 23% Jobs, FDA Oks New Drug For Hypoparathyroidism, SIGA Down But Not Out (RTTNews)
16.08.24	AstraZeneca's Imfinzi Gets US Approval For Resectable Early-stage Lung Cancer (RTTNews)
15.08.24	AstraZeneca Says FDA Granted Priority Review For Imfinzi In Limited-stage Small Cell Lung Cancer (RTTNews)
08.08.24	Conduit Pharmaceuticals Shares Soar In Pre-market, Why? (RTTNews)
29.07.24	AstraZeneca: Calquence Combo Enhances PFS In First-Line CLL In Phase III Trial (RTTNews)
26.07.24	AstraZeneca Reports ODAC's Review Of Imfinzi - Quick Facts (RTTNews)
25.07.24	AstraZeneca Q2 Profit Rises, Lifts FY24 Outlook (RTTNews)
01.07.24	AstraZeneca: CHMP Recommends Lynparza And Imfinzi Combination For EU Approval In Endometrial Cancer (RTTNews)
28.06.24	Biotech Stocks Facing FDA Decision In July 2024 (RTTNews)
25.06.24	AstraZeneca: Imfinzi Trial Fails To Meet Endpoint In Early-stage Non-small Cell Lung Cancer (RTTNews)
18.06.24	AstraZeneca: Phase III Truqap Trial Plus Chemotherapy Fails To Meet Primary Goals In Breast Cancer (RTTNews)
16.06.24	AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial (RTTNews)
13.06.24	FDA Approves AstraZeneca's Farxiga For Pediatric Use In Type-2 Diabetes (RTTNews)
05.06.24	AstraZeneca Completes Acquisition Of Fusion Pharma (RTTNews)
03.06.24	CHMP Recommends Approval Of AstraZeneca's Tagrisso Combo For EGFR-Mutated Advanced Lung Cancer (RTTNews)
30.05.24	Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris (RTTNews)
27.05.24	AZN:Datopotamab Deruxtecan Shows Favorable Survival Results, Falls Short Of Statistical Significance (RTTNews)
21.05.24	AstraZeneca Targets $80 Bln Revenue By 2030, Plans To Launch 20 New Medicines (RTTNews)
20.05.24	AstraZeneca To Build $1.5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates (RTTNews)
20.05.24	AstraZeneca: New Data Shows Tezspire's Role In Future COPD Treatment (RTTNews)
16.05.24	AZN:Phase III Trial Of Sipavibart Met Main Goal In Preventing COVID-19 In Immunocompromised Patients (RTTNews)
13.05.24	Amazon, Microsoft, Pfizer To Invest Billions In French Projects (RTTNews)
08.05.24	AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

18.12.24		Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer
04.12.24		Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich
03.12.24		Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende
03.12.24		Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus
03.12.24		Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück
03.12.24		NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer
12.11.24		AstraZeneca-Aktie im Minus: AstraZeneca meldet starkes 3. Quartal und passt Prognose nach oben an
07.11.24		AstraZeneca-Aktie rutscht ab: Festnahme des China-Chefs von AstraZeneca

18.12.24

Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer

04.12.24

Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich

03.12.24

Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende

03.12.24

Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus

03.12.24

Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück

03.12.24

NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer

12.11.24

AstraZeneca-Aktie im Minus: AstraZeneca meldet starkes 3. Quartal und passt Prognose nach oben an

07.11.24

AstraZeneca-Aktie rutscht ab: Festnahme des China-Chefs von AstraZeneca

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nestle	74.20	0.13 %	K V
Swiss Life Hldg	689.40	0.06 %	K V
Kuehne+Nagel Int	202.30	0.00 %	K V
Swisscom	501.50	-0.30 %	K V
Swiss Re	129.10	-0.39 %	K V
Logitech Intl	73.02	-2.41 %	K V
Roche Hldg G	246.70	-3.25 %	K V
UBS Group	26.89	-3.34 %	K V
Part Grp Hldg	1’217.00	-4.29 %	K V
ABB	48.73	-5.42 %	K V

Nachrichten zu AstraZeneca PLC (spons. ADRs)

Aktien Top/Flop

AstraZeneca Peer Group Nachrichten

Meistgelesene Nachrichten